Comparison of Two Apical Repair Methods in Women Undergoing Repairs for Prolapse
- Conditions
- Quality of LifeComplicationPelvic Organ ProlapseSurgery
- Interventions
- Procedure: fixation of the vaginal apex
- Registration Number
- NCT03113513
- Lead Sponsor
- Medical University of Graz
- Brief Summary
To date no study has determined prospectively which technique is superior to prevent recurrent Pelvic Organ Prolapse (POP) after vaginal hysterectomy- a major unmet clinical need. The aim of the study is to determine objective anatomical recurrent prolapse after Sacrospinous Ligament Fixation (SLF) vs McCall.
- Detailed Description
The aim of the study is to determine objective anatomical recurrent prolapse after SLF vs McCall. The study is designed as a Randomized Controlled Trial (RCT). Primary study endpoint will be at 12 months, secondary study endpoint at 24 months. The following parameters will be evaluated after one year: anatomical outcome, Quality of Life (QoL), sexual health, reoperations, and complications.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- Female
- Target Recruitment
- 312
- declined/ failed conservative treatment for POP
- planned vaginal hysterectomy with anterior/posterior colporrhaphy as indicated
- any symptomatic POP or stage II prolapse in any compartment
- at least stage I prolapse in the apical department
- women between 35 and 80 years of age
- good German language skills
- any concomitant prolapse surgery (anterior, posterior vaginal repair, suburethral tapes) as indicated
- concomitant salpingo-oophorectomy if indicated
- Unwillingness to participate
- Neurological disorders
- Previous hysterectomy
- Desire to have children
- Connective tissue disorders (i.e. Ehlers-Danlos syndrome, Marfan syndrome)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description McCall culdoplasty fixation of the vaginal apex The McCall culdoplasty will be performed in a modified version as described by McCall in 1957. Specifically, two long acting bioresorbable sutures are put through the specific anatomic landmarks. Sacrospinous ligament fixation fixation of the vaginal apex The SLF technique will be performed as described by Richter et al (Amreich, 1951). Two long acting bioresorbable sutures are passed through the right sacrospinous ligament and then fixed to the vaginal cuff.
- Primary Outcome Measures
Name Time Method Number of patients with stage 2 or higher on the Pelvic Organ Prolapse Quantification System (POP-Q). 12 months after surgery POP-Q stage 2 or higher means any point of the POP-Q system being -1 related to the hymen or below
- Secondary Outcome Measures
Name Time Method Subjective cure 12 months after surgery determined by the Patient Global Impression of Improvement (PGII) index
Quality of life as determined by a questionnaire 12 months after surgery The Kings Health Questionnaire was validated in women with stress urinary incontinence and assesses the impact of incontinence on quality of life. The eight subscales ("domains") scored between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst); lower scores indicate better QoL. Success in terms of the study is defined as 10 points improvement on the total Kings Health Questionnaire score.
Reoperation rate 12 months after surgery Number of patients with any reoperations for POP
Sexual health 12 months after surgery The Pelvic Organ Prolapse Incontinence Sexual Questionnaire is a 20 item questionnaire and is the primary measure used to assess sexual function in women with urinary incontinence and prolapse. Mean subscale scores are calculated by summing the valid responses to items in the subscale and then divided by the number of items with valid responses. The higher the subscores, the worse the outcome.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
MUGRAZ
🇦🇹Graz, Styria, Austria